| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |